ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gonadotropin-releasing Hormone Agonist Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7X1213
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gonadotropin releasing Hormone Agonist Drugs Market Research Report 2020
BUY CHAPTERS

Global Gonadotropin-releasing Hormone Agonist Drugs Market Research Report 2025

Code: QYRE-Auto-7X1213
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Astrazeneca plc
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen S A
Sanofi
Endo

Gonadotropin-releasing Hormone Agonist Drugs Market Size

The global market for Gonadotropin-releasing Hormone Agonist Drugs was valued at US$ 4285 million in the year 2024 and is projected to reach a revised size of US$ 4684 million by 2031, growing at a CAGR of 1.3% during the forecast period.

Gonadotropin-releasing Hormone Agonist Drugs Market

Gonadotropin-releasing Hormone Agonist Drugs Market

Gonadotropin-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. 
The Luteinizing Hormone-releasing Hormone (LHRH) Analogs market is primarily driven by the demand for hormone therapy options in managing hormone-dependent conditions such as prostate cancer and certain gynecological disorders. LHRH analogs, also known as LHRH agonists, are medications that suppress the release of sex hormones by altering the signaling of the hypothalamus-pituitary-gonadal axis. The increasing prevalence of hormone-related diseases, coupled with advancements in oncology and reproductive medicine, contributes to market growth. Moreover, the demonstrated benefits of LHRH analogs in reducing hormone levels and controlling tumor growth further propel adoption. However, challenges include optimizing treatment regimens for specific conditions and addressing potential side effects such as hormonal imbalances and bone density loss. Navigating personalized treatment plans, managing patient expectations, and ensuring long-term safety and efficacy are ongoing concerns. The market"s success relies on continuous research in endocrinology and oncology, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of LHRH analog treatments while addressing the evolving challenges associated with hormone-related diseases and treatment customization.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gonadotropin-releasing Hormone Agonist Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadotropin-releasing Hormone Agonist Drugs.
The Gonadotropin-releasing Hormone Agonist Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gonadotropin-releasing Hormone Agonist Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadotropin-releasing Hormone Agonist Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gonadotropin-releasing Hormone Agonist Drugs Market Report

Report Metric Details
Report Name Gonadotropin-releasing Hormone Agonist Drugs Market
Accounted market size in year US$ 4285 million
Forecasted market size in 2031 US$ 4684 million
CAGR 1.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Takeda, LIVZON, Ipsen, Sanofi, Endo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gonadotropin-releasing Hormone Agonist Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gonadotropin-releasing Hormone Agonist Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gonadotropin-releasing Hormone Agonist Drugs Market growing?

Ans: The Gonadotropin-releasing Hormone Agonist Drugs Market witnessing a CAGR of 1.3% during the forecast period 2025-2031.

What is the Gonadotropin-releasing Hormone Agonist Drugs Market size in 2031?

Ans: The Gonadotropin-releasing Hormone Agonist Drugs Market size in 2031 will be US$ 4684 million.

Who are the main players in the Gonadotropin-releasing Hormone Agonist Drugs Market report?

Ans: The main players in the Gonadotropin-releasing Hormone Agonist Drugs Market are AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Takeda, LIVZON, Ipsen, Sanofi, Endo

What are the Application segmentation covered in the Gonadotropin-releasing Hormone Agonist Drugs Market report?

Ans: The Applications covered in the Gonadotropin-releasing Hormone Agonist Drugs Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Gonadotropin-releasing Hormone Agonist Drugs Market report?

Ans: The Types covered in the Gonadotropin-releasing Hormone Agonist Drugs Market report are Leuprorelin, Goserelin, Taltirelin, Histrelin, Other

Recommended Reports

Hormonal Therapy Drugs

Prostate & Cancer Drugs

Reproductive Treatments

1 Gonadotropin-releasing Hormone Agonist Drugs Market Overview
1.1 Product Definition
1.2 Gonadotropin-releasing Hormone Agonist Drugs by Type
1.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Gonadotropin-releasing Hormone Agonist Drugs by Application
1.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue 2020-2031
1.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales 2020-2031
1.4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gonadotropin-releasing Hormone Agonist Drugs Market Competition by Manufacturers
2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gonadotropin-releasing Hormone Agonist Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Date of Enter into This Industry
2.8 Global Gonadotropin-releasing Hormone Agonist Drugs Market Competitive Situation and Trends
2.8.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gonadotropin-releasing Hormone Agonist Drugs Players Market Share by Revenue
2.8.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Scenario by Region
3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region: 2020-2031
3.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region: 2020-2025
3.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region: 2026-2031
3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2020-2031
3.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2020-2025
3.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2026-2031
3.4 North America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.4.1 North America Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2031)
3.4.3 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.5.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2031)
3.5.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.7.1 Latin America Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2020-2031)
4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2020-2025)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2026-2031)
4.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2020-2031)
4.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2020-2025)
4.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2026-2031)
4.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2020-2031)
5.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2020-2025)
5.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2026-2031)
5.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2020-2031)
5.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2020-2025)
5.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2026-2031)
5.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ferring
6.3.1 Ferring Company Information
6.3.2 Ferring Description and Business Overview
6.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ferring Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.3.5 Ferring Recent Developments/Updates
6.4 TerSera Therapeutics
6.4.1 TerSera Therapeutics Company Information
6.4.2 TerSera Therapeutics Description and Business Overview
6.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.4.5 TerSera Therapeutics Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takeda Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 LIVZON
6.6.1 LIVZON Company Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.6.5 LIVZON Recent Developments/Updates
6.7 Ipsen
6.7.1 Ipsen Company Information
6.7.2 Ipsen Description and Business Overview
6.7.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo
6.9.1 Endo Company Information
6.9.2 Endo Description and Business Overview
6.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Endo Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.9.5 Endo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gonadotropin-releasing Hormone Agonist Drugs Industry Chain Analysis
7.2 Gonadotropin-releasing Hormone Agonist Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadotropin-releasing Hormone Agonist Drugs Production Mode & Process Analysis
7.4 Gonadotropin-releasing Hormone Agonist Drugs Sales and Marketing
7.4.1 Gonadotropin-releasing Hormone Agonist Drugs Sales Channels
7.4.2 Gonadotropin-releasing Hormone Agonist Drugs Distributors
7.5 Gonadotropin-releasing Hormone Agonist Drugs Customer Analysis
8 Gonadotropin-releasing Hormone Agonist Drugs Market Dynamics
8.1 Gonadotropin-releasing Hormone Agonist Drugs Industry Trends
8.2 Gonadotropin-releasing Hormone Agonist Drugs Market Drivers
8.3 Gonadotropin-releasing Hormone Agonist Drugs Market Challenges
8.4 Gonadotropin-releasing Hormone Agonist Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Astrazeneca plc
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen S A
Sanofi
Endo
List of Tables
 Table 1. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gonadotropin-releasing Hormone Agonist Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gonadotropin-releasing Hormone Agonist Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gonadotropin-releasing Hormone Agonist Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gonadotropin-releasing Hormone Agonist Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Agonist Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Ferring Company Information
 Table 81. Ferring Description and Business Overview
 Table 82. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Ferring Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 84. Ferring Recent Developments/Updates
 Table 85. TerSera Therapeutics Company Information
 Table 86. TerSera Therapeutics Description and Business Overview
 Table 87. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 89. TerSera Therapeutics Recent Developments/Updates
 Table 90. Takeda Company Information
 Table 91. Takeda Description and Business Overview
 Table 92. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Takeda Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 94. Takeda Recent Developments/Updates
 Table 95. LIVZON Company Information
 Table 96. LIVZON Description and Business Overview
 Table 97. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 99. LIVZON Recent Developments/Updates
 Table 100. Ipsen Company Information
 Table 101. Ipsen Description and Business Overview
 Table 102. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 104. Ipsen Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Endo Company Information
 Table 111. Endo Description and Business Overview
 Table 112. Endo Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Endo Gonadotropin-releasing Hormone Agonist Drugs Product
 Table 114. Endo Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Gonadotropin-releasing Hormone Agonist Drugs Distributors List
 Table 118. Gonadotropin-releasing Hormone Agonist Drugs Customers List
 Table 119. Gonadotropin-releasing Hormone Agonist Drugs Market Trends
 Table 120. Gonadotropin-releasing Hormone Agonist Drugs Market Drivers
 Table 121. Gonadotropin-releasing Hormone Agonist Drugs Market Challenges
 Table 122. Gonadotropin-releasing Hormone Agonist Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gonadotropin-releasing Hormone Agonist Drugs
 Figure 2. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Type: 2024 & 2031
 Figure 4. Leuprorelin Product Picture
 Figure 5. Goserelin Product Picture
 Figure 6. Taltirelin Product Picture
 Figure 7. Histrelin Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Pharmacy
 Figure 13. Other
 Figure 14. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Gonadotropin-releasing Hormone Agonist Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 18. Gonadotropin-releasing Hormone Agonist Drugs Report Years Considered
 Figure 19. Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Gonadotropin-releasing Hormone Agonist Drugs Players: Market Share by Revenue in Gonadotropin-releasing Hormone Agonist Drugs in 2024
 Figure 22. Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. United States Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type (2020-2031)
 Figure 58. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Application (2020-2031)
 Figure 61. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 62. Gonadotropin-releasing Hormone Agonist Drugs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GnRH Agonist Market Research Report 2024
Global Gonadorelin Market Insights Forecast to 2030
Global Gonadotropin releasing Hormone Antagonists Market Research Report 2024
Global Gonadorelin Acetate Market Insights Forecast to 2030
Cetrotide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Leuprorelin Drugs Market Research Report 2024
Global Hormone Releasing Agonists Market Research Report 2024
Global GnRH Analogues Market Research Report 2024
Global GnRH Receptor Antagonists Market Research Report 2024
Global Follicle Stimulating Hormone Market Research Report 2025
Global Buserelin Market Research Report 2024
Global Oral GnRH Drugs Market Research Report 2024
Global Ovulation Inducing Drugs Market Research Report 2024
Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Luteinizing Hormone Releasing Antagonist Market Research Report 2024
Global Recombinant FSH Injections Market Research Report 2024
Global Infertility Treatment Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions